院内感染対策市場：タイプ、適応症、エンドユーザー別- 世界予測2024-2030年

院内感染対策市場規模は2023年に342億6,000万米ドルと推計され、2024年には363億9,000万米ドルに達し、CAGR 6.48％で2030年には532億米ドルに達すると予測されます。

院内感染（HAI）対策とは、病院やその他の医療施設に入院中の患者が獲得する感染症を予防・管理するために、医療機関が行う体系的なアプローチと献身的な取り組みを指します。これらの感染症は、細菌、ウイルス、真菌、その他の病原体など、様々な微生物にさらされた結果として発生します。その対策は、厳格な衛生習慣、滅菌・消毒手順、個人防護具（PPE）の使用、感染症のサーベイランス、侵襲的処置や抗生物質管理に関するプロトコルの遵守など、幅広い戦略に及んでいます。ヘルスケア環境における感染症に対する意識の高まりと、感染管理政策の急速な重視が相まって、市場の成長を後押ししています。しかし、高度な感染制御技術に関連する高コストは、資源が限られた環境では法外な負担となる可能性があります。さらに、滅菌・消毒プロセスの技術的進歩や、環境にやさしく効率的な消毒剤の開発が、メーカーに大きなチャンスをもたらしています。

タイプ診断・検査機器の継続的な技術進歩による効率性の向上

診断・検査機器は、院内感染（HAI）の特定と管理に不可欠なコンポーネントです。この分野には、臨床現場で病原体を迅速に検出するための機器やキットが含まれます。ポリメラーゼ連鎖反応（PCR）や酵素結合免疫吸着測定法（ELISA）などの先進技術を活用したこの機器は、感染の早期診断とモニタリングに役立ち、タイムリーな介入と治療を可能にします。消毒製品は、ヘルスケア施設内での感染拡大を防ぐ上で極めて重要な役割を果たします。消毒製品には、さまざまな表面上の感染性生物を破壊または不活性化するように設計された、化学的および非化学的な薬剤が幅広く含まれています。その中には消毒剤、滅菌剤、防腐剤などがあり、医療機器、病床、その他の接触頻度の高い部位に使用することで、無菌環境を維持し、感染伝播のリスクを最小限に抑えることができます。手指の感染は感染拡大の主要な経路であることから、手指衛生製品はHAIとの戦いにおいて不可欠です。このカテゴリーには抗菌性ハンドウォッシュ、ハンドラブ、サニタイザーが含まれ、これらは効果的に細菌を殺菌し、医療従事者、患者、面会者の手に有害な細菌が定着するのを防ぐよう処方されています。個人防護具（Personal Protective Equipment：PPE）は、医療従事者や患者が感染源にさらされないように防護するための衣服や装備品です。PPEには、マスク、ガウン、フェイスシールドなどが含まれ、感染症の伝播を防ぐバリアとして機能します。PPEは、特に伝染性の強い病気が発生した際に非常に重要であり、HAIの蔓延を抑え、ヘルスケア環境における個人の健康を守るために役立っています。滅菌機器には、オートクレーブ、加熱滅菌器、低温滅菌器などがあり、医療器具や医療機器を病原体フリーにするために不可欠です。サイクルタイム、能力、エネルギー効率などの要素が、その好みを左右します。

エンドユーザー病院とICUは、リスクの高い環境向けの包括的で自動化されたソリューションを重視します。

外来手術・診断センターは、手術や診断処置のために短期間患者をケアするのが特徴です。これらのセンターにおけるHAI対策のニーズは、患者のスループットが高く、迅速なターンアラウンドタイムが必要であることから、効率的な滅菌機器と滅菌方法に重点が置かれています。病院と集中治療室（ICU）は、重症患者を治療する中心的な施設であり、HAI予防が最も重要です。これらの施設では、空気ろ過、表面消毒、厳格な滅菌プロトコルを含む包括的な感染制御ソリューションが必要です。ナーシングホームとマタニティセンターは、患者の属性は異なるもの、HAIに対する患者の脆弱性に対する懸念は共通しています。これらの環境における感染対策では、穏やかでありながら効果的な消毒方法と、長期間の曝露にも安全な製品が重視されています。

地域別の洞察

米国とカナダに代表される南北アメリカは、厳しい規制基準と高水準のヘルスケア支出に起因して、HAI対策ソリューションに対する旺盛な需要を示しています。技術革新と技術進歩が主要因であり、無害で環境に優しい消毒法とスマートモニタリングシステムに重点が置かれています。欧州連合（EU）では、厳格な規制とヘルスケアの認定・品質重視が、高水準のHAI管理ソリューションへの需要を後押ししています。EU全体のイニシアチブは、感染制御慣行の調和、HAI研究における国境を越えた協力の強化、技術革新の促進を目指しています。中東ではヘルスケアの変革が進んでおり、病院のインフラ整備や質の向上への取り組みに多額の投資が行われています。一部の国では費用対効果の高いソリューションが好まれるもの、高度な感染制御技術に対する需要が高まっています。アジア太平洋地域は、ヘルスケアインフラの成長と感染予防プロトコルに対する意識の高まりにより、先進的なHAI管理ソリューションの急速な導入が注目されています。中国と日本はAPACの中でも研究開発に多額の投資を行っている著名な国であり、インドは病院数の増加とヘルスケアの質重視により、重要な市場として台頭してきています。この地域の顧客の購買行動は、コスト効率と有効性の両方を提供する統合ソリューションに傾いています。

FPNVポジショニング・マトリックス

FPNVポジショニング・マトリックスは院内感染対策市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、院内感染対策市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.院内感染対策市場の市場規模および予測は？

2.院内感染対策市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.院内感染対策市場の技術動向と規制枠組みは？

4.院内感染対策市場における主要ベンダーの市場シェアは？

5.院内感染対策市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ヘルスケア現場における感染に対する意識が高まり、感染制御政策の重要性が高まっている
    • 高齢化人口の増加に伴い慢性疾患の罹患率も増加
    • ヘルスケア業界における消毒剤と医療用不織布の使用増加
  • 抑制要因
    • 内視鏡再処理装置と微生物検査機器に関連する高コスト
  • 機会
    • 研究開発への投資の増加と病院における消耗品の使用量の増加
    • 殺菌・消毒プロセスと感染制御機器の技術的進歩
  • 課題
    • 再処理された器具の安全性に関する懸念
• 市場セグメンテーション分析
  • タイプ：効率性を高めるための診断および検査機器の継続的な技術進歩
  • エンドユーザー：病院とICUは、高リスク環境向けの包括的かつ自動化されたソリューションを重視しています。
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 院内感染対策市場：タイプ別

• 診断および検査機器
• 消毒製品
• 手指衛生製品
• 個人用保護具
• 滅菌装置

第7章 院内感染対策市場適応症別

• 血流感染症
• クロストリディオイデス・ディフィシル感染症
• 院内肺炎
• 多剤耐性菌
• 手術部位感染
• 尿路感染症

第8章 院内感染対策市場：エンドユーザー別

• 外来手術・診断センター
• 病院とICU
• 介護施設と産科センター

第9章 南北アメリカの院内感染対策市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の院内感染対策市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの院内感染対策市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • アルストロム、次世代同時殺菌ラップ「リライアンスフュージョン」を発売
  • PAMAが新しいエチレンオキシド殺菌ソリューションを発表
• 戦略分析と提言

第13章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. HOSPITAL ACQUIRED INFECTION CONTROL MARKET RESEARCH PROCESS
• FIGURE 2. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. HOSPITAL ACQUIRED INFECTION CONTROL MARKET DYNAMICS
• FIGURE 7. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. HOSPITAL ACQUIRED INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DIAGNOSTIC & TESTING EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DIAGNOSTIC & TESTING EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTION PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTION PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HAND HYGIENE PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HAND HYGIENE PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY CLOSTRIDIOIDES DIFFICILE INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY CLOSTRIDIOIDES DIFFICILE INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITAL-ACQUIRED PNEUMONIA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITAL-ACQUIRED PNEUMONIA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY MULTIDRUG-RESISTANT ORGANISMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY MULTIDRUG-RESISTANT ORGANISMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY SURGICAL SITE INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY SURGICAL SITE INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY AMBULATORY SURGICAL & DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY AMBULATORY SURGICAL & DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITALS & ICUS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITALS & ICUS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY NURSING HOMES & MATERNITY CENTERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY NURSING HOMES & MATERNITY CENTERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 42. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 43. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 44. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 45. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 46. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 47. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 48. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 49. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 50. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 51. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 52. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 53. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 54. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 55. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 56. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 57. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 58. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 59. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 60. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 61. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 62. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 63. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 64. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 65. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 66. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 67. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 68. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 69. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 70. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 71. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 72. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 73. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 74. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 75. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 76. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 77. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 78. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 79. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 80. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 82. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 84. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 86. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 88. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 89. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 90. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 91. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 92. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 93. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 94. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 95. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 96. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 97. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 98. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 99. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 100. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 101. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 102. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 103. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 104. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 105. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 106. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 107. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 108. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 109. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 110. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 111. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 112. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 113. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 114. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 115. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 116. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 117. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 118. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 119. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 120. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 121. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 122. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 123. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 124. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 125. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 126. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 127. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 128. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 129. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 130. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 131. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 132. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 133. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 134. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 135. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 136. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 137. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 138. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 139. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 140. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 141. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 142. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 143. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 144. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 145. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 146. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 147. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 148. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 149. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 150. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 151. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 152. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 153. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 154. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 155. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 156. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 157. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 158. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 159. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 160. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 161. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 162. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 163. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 164. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 165. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 166. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 167. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 168. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 169. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 170. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 171. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 172. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 173. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 174. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 175. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 176. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 177. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 178. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 179. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 180. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 181. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 182. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 183. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 184. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 185. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 186. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 187. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 188. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 189. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 190. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 191. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 192. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 193. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 194. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 195. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 196. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 197. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 198. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 199. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 200. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 201. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 202. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 203. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 204. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 205. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 206. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 207. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 208. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 209. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 210. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 211. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 212. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 213. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 214. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 215. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 216. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 217. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 218. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 219. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 220. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 221. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 222. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 223. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 224. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 225. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 226. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 227. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 228. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 229. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 230. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 231. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 232. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 233. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 234. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 235. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 236. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 237. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 238. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 239. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 240. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 241. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 242. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 243. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 244. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 245. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 246. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 247. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 248. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 249. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 250. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 251. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 252. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 253. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 254. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 255. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 256. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 257. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 258. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 259. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 260. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 261. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 262. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 263. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 264. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 265. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 266. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 267. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 268. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 269. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 270. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 271. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 272. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 273. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 274. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 275. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 276. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 277. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 278. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 279. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 280. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 281. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 282. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 283. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 284. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 285. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 286. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 287. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 288. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 289. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 290. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 291. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 292. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 293. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 294. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 295. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 296. HOSPITAL ACQUIRED INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023

[194 Pages Report] The Hospital Acquired Infection Control Market size was estimated at USD 34.26 billion in 2023 and expected to reach USD 36.39 billion in 2024, at a CAGR 6.48% to reach USD 53.20 billion by 2030.

Hospital acquired infection (HAI) control refers to the systematic approach and dedicated efforts undertaken by healthcare institutions to prevent and manage infections acquired by patients during their stay in hospitals & other healthcare facilities. These infections can occur as a result of exposure to various microbial agents, including bacteria, viruses, fungi, and other pathogens. The control measures span a wide range of strategies, including rigorous hygiene practices, sterilization and disinfection procedures, use of personal protective equipment (PPE), surveillance of infections, and adherence to protocols for invasive procedures and antibiotic stewardship. The rising awareness about infections acquired in healthcare settings, coupled with a rapidly growing emphasis on infection control policies, boosts the market growth. However, high costs associated with advanced infection control technologies can be prohibitive for resource-limited settings. Furthermore, technological advancements in sterilization and disinfection processes, along with the development of eco-friendly and more efficient disinfectants, pose significant opportunities to the manufacturers.

Type: Ongoing technological advancements in diagnostic and testing equipment to increase efficiency

Diagnostic and testing equipment constitute critical components in the identification and management of hospital-acquired infections (HAIs). This segment includes devices and kits used for the rapid detection of pathogens in clinical settings. Leveraging advanced technologies, such as polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA), this equipment helps in the early diagnosis and monitoring of infections, enabling timely intervention and treatment. Disinfection products play a pivotal role in preventing the spread of infections within healthcare facilities. Disinfection products encompass a wide range of chemical and non-chemical agents designed to destroy or inactivate infectious organisms on various surfaces. Among these are disinfectants, sterilants, and antiseptics, which are used on medical equipment, hospital beds, and other high-touch areas to maintain a sterile environment and minimize the risk of infection transmission. Hand hygiene products are essential in the battle against HAIs, given that hand transmission is a major pathway for the spread of infections. This category includes antibacterial hand washes, hand rubs, and sanitizers, which are formulated to effectively kill germs and prevent the colonization of harmful bacteria on the hands of healthcare workers, patients, and visitors. Personal Protective Equipment (PPE) consists of garments and gear designed to protect healthcare workers and patients from being exposed to infectious agents. PPE includes items such as masks, gowns, and face shields, which act as barriers to the transmission of infections. Especially crucial during outbreaks of highly contagious diseases, PPE is instrumental in reducing the spread of HAIs and safeguarding the health of individuals within the healthcare environment. Sterilization equipment encompasses autoclaves, heat sterilizers, and low-temperature sterilizers, crucial for rendering medical instruments and devices pathogen-free. Factors such as cycle time, capacity, and energy efficiency govern their preference.

End-user: Hospitals & ICUs emphasize comprehensive and automated solutions for high-risk environments

Ambulatory surgical & diagnostic centers are characterized by their short-term patient care for surgical and diagnostic procedures. The need for HAI control in these centers focuses on efficient sterilization equipment and practices, given the high throughput of patients and the necessity for quick turnaround times. Hospitals and Intensive Care Units (ICUs) are the epicenters for treating critical patients, making HAI prevention paramount. These facilities require comprehensive infection control solutions that encompass air filtration, surface disinfection, and stringent sterilization protocols. Nursing homes and maternity centers, while differing in patient demographics, share concerns over the vulnerability of their populations to HAIs. Infection control in these settings emphasizes gentle yet effective disinfection methods and products that are safe for long-term exposure.

Regional Insights

The Americas, led by the United States and Canada, exhibit a robust demand for HAI control solutions, attributed to stringent regulatory standards and a high level of healthcare expenditure. Innovation and technological advancement are key factors, with a focus on non-toxic, eco-friendly disinfection methods and smart monitoring systems. In the European Union, stringent regulations and a focus on accreditation and quality in healthcare drive the demand for high-standard HAI control solutions. EU-wide initiatives aim at harmonizing infection control practices, enhancing cross-border cooperation in HAI research, and fostering innovation. The Middle East is witnessing a healthcare transformation, with significant investments in hospital infrastructure and quality improvement initiatives. There is an increasing demand for advanced infection control technologies, albeit with a preference for cost-effective solutions in some countries. The Asia Pacific region is noted for its rapid adoption of advanced HAI control solutions, driven by growing healthcare infrastructure and heightened awareness of infection-prevention protocols. China and Japan are prominent countries in APAC with substantial investments in R&D, while India is emerging as a substantial market due to its increasing number of hospitals and focus on healthcare quality. Customer purchasing behavior in this region leans towards integrated solutions offering both cost efficiency and effectiveness.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Hospital Acquired Infection Control Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Hospital Acquired Infection Control Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Hospital Acquired Infection Control Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Advanced Sterilization Products Services Inc., AHLSTROM OYJ, Becton, Dickinson and Company, Belimed AG, Cantel Medical Corporation by STERIS PLC, Cardinal Health, Inc., DNV AS, Ecolab Inc., F. Hoffmann-La Roche Ltd, GOJO Industries, Inc., Henkel AG & Co. KGaA, Kimberly-Clark Corporation, Medline Industries, LP, Olympus Corporation, Sterigenics International LLC, and Unilever PLC.

Market Segmentation & Coverage

This research report categorizes the Hospital Acquired Infection Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Type
  • Diagnostic & Testing Equipment
  • Disinfection Products
  • Hand Hygiene Products
  • Personal Protective Equipment
  • Sterilization Equipment

• Indication
  • Bloodstream Infections
  • Clostridioides difficile Infections
  • Hospital-acquired Pneumonia
  • Multidrug-Resistant Organisms
  • Surgical Site Infections
  • Urinary Tract Infections

• End-user
  • Ambulatory Surgical & Diagnostic Centers
  • Hospitals & ICUs
  • Nursing Homes & Maternity Centers

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Hospital Acquired Infection Control Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Hospital Acquired Infection Control Market?

3. What are the technology trends and regulatory frameworks in the Hospital Acquired Infection Control Market?

4. What is the market share of the leading vendors in the Hospital Acquired Infection Control Market?

5. Which modes and strategic moves are suitable for entering the Hospital Acquired Infection Control Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising awareness about infections in healthcare settings with growing emphasis on infection control policies
    • 5.1.1.2. Growing prevalence of chronic diseases with increasing geriatric population
    • 5.1.1.3. Increasing use of disinfectants and medical nonwovens in the healthcare industry
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the endoscope reprocessors and microbial testing instruments
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing investments in R&D coupled with high usage of consumables in hospitals
    • 5.1.3.2. Technological advancements in sterilization & disinfection processes and infection control devices
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with the safety of reprocessed instruments
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Ongoing technological advancements in diagnostic and testing equipment to increase efficiency
  • 5.2.2. End-user: Hospitals & ICUs emphasize comprehensive and automated solutions for high-risk environments
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Hospital Acquired Infection Control Market, by Type

• 6.1. Introduction
• 6.2. Diagnostic & Testing Equipment
• 6.3. Disinfection Products
• 6.4. Hand Hygiene Products
• 6.5. Personal Protective Equipment
• 6.6. Sterilization Equipment

7. Hospital Acquired Infection Control Market, by Indication

• 7.1. Introduction
• 7.2. Bloodstream Infections
• 7.3. Clostridioides difficile Infections
• 7.4. Hospital-acquired Pneumonia
• 7.5. Multidrug-Resistant Organisms
• 7.6. Surgical Site Infections
• 7.7. Urinary Tract Infections

8. Hospital Acquired Infection Control Market, by End-user

• 8.1. Introduction
• 8.2. Ambulatory Surgical & Diagnostic Centers
• 8.3. Hospitals & ICUs
• 8.4. Nursing Homes & Maternity Centers

9. Americas Hospital Acquired Infection Control Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Hospital Acquired Infection Control Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Hospital Acquired Infection Control Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Ahlstrom launches Reliance Fusion next-generation simultaneous sterilization wrap
  • 12.3.2. PAMA introduces new ethylene oxide sterilisation solution
• 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio